Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
State Street SPDR S&P Pharmaceuticals ETF
(NY:
XPH
)
67.51
-0.50 (-0.74%)
Official Closing Price
Updated: 8:00 PM EDT, Sep 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
425,409
Open
68.58
Bid (Size)
67.17 (4,500)
Ask (Size)
68.17 (4,400)
Prev. Close
68.01
Today's Range
67.51 - 69.03
52wk Range
45.80 - 74.34
Shares Outstanding
36,002
Dividend Yield
0.35%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
IXJ vs XPH: Global Healthcare ETF or Pharma Focus?
↗
September 11, 2026
XPH delivered 57% returns over one year but swung 31% lower at its worst. IXJ offers steadier performance with higher income and $4.2 billion in assets for easier trading.
Via
The Motley Fool
Topics
ETFs
Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH
↗
September 10, 2026
Vanguard's broader healthcare portfolio charges less and yields more, but State Street's pharma-focused fund has delivered stronger recent gains despite higher volatility.
Via
The Motley Fool
Topics
ETFs
Performance
YTD
+22.3%
+22.3%
1 Month
-3.3%
-3.3%
3 Month
+12.0%
+12.0%
6 Month
+26.8%
+26.8%
1 Year
+41.8%
+41.8%
More News
Read More
Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH?
↗
September 10, 2026
Via
The Motley Fool
Topics
ETFs
Why Did AQST Stock Plunge 40% In Pre-Market Today?
↗
January 09, 2026
Via
Stocktwits
XPH vs PJP: Which Pharma ETF Offers Better Value
↗
August 17, 2026
Via
The Motley Fool
Topics
ETFs
Better Healthcare ETF: State Street's Pharmaceuticals-Focused XPH vs. Invesco's S&P 500-Targeted RSPH
↗
August 12, 2026
Via
The Motley Fool
Topics
ETFs
Stocks
Which Pharmaceuticals ETF Is Better, the iShares IHE or State Street XPH?
↗
July 16, 2026
Via
The Motley Fool
Topics
ETFs
Which Healthcare ETF Is the Better Buy: Invesco's IBBQ or State Street's XPH?
↗
July 08, 2026
Via
The Motley Fool
Topics
ETFs
BBH vs. XPH: Which Healthcare ETF Is Better for Beginners?
↗
July 08, 2026
Via
The Motley Fool
Topics
ETFs
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio?
↗
June 04, 2026
Via
The Motley Fool
Topics
ETFs
Stocks
Biotech ETFs: Which ETF Offers Lower Fees? IBBQ or XPH?
↗
June 04, 2026
Via
The Motley Fool
Topics
ETFs
ESPR Stock Falls After Esperion’s Mixed Q4 — Retail Remains Unfazed, Eyes ‘Massive’ Upcoming Catalysts
↗
March 10, 2026
Via
Stocktwits
Topics
Intellectual Property
Why Did CANF Stock Soar 40% In Pre-Market Today?
↗
March 04, 2026
Via
Stocktwits
TBPH Stock Slumps 30%, Falls Below 200-DMA For First Time In Over 9 Months As Phase 3 Study Misses Primary Endpoint
↗
March 03, 2026
Via
Stocktwits
Topics
Workforce
FDA Commissioner Raises Concerns About US Pharma Lagging Behind China In Drug Development
↗
February 18, 2026
Via
Stocktwits
Topics
ETFs
Government
NKTR Stock Soars After Nektar Reports Positive Atopic Dermatitis Trial Results
↗
February 10, 2026
Via
Stocktwits
Why Did CRMD Stock Crash 28% Today?
↗
January 08, 2026
Via
Stocktwits
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'
↗
November 12, 2025
Via
Benzinga
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk
↗
September 29, 2025
Via
Benzinga
Topics
ETFs
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms
↗
September 29, 2025
Via
Benzinga
Topics
Government
World Trade
Pharma Tariffs Back In Spotlight On New Trump Threat
↗
September 26, 2025
Via
Investor's Business Daily
Topics
ETFs
Government
World Trade
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing
↗
September 08, 2025
Via
Benzinga
Drug Tariffs Finally Land. Why Pharma Stocks Are Breathing Easy.
↗
August 22, 2025
Via
Investor's Business Daily
Topics
ETFs
Government
Intellectual Property
Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More'
↗
August 01, 2025
Via
Benzinga
Novo Nordisk Shares Plunge Amid Leadership Shakeup (NYSE:NVO)
July 29, 2025
Via
MarketMinute
Topics
ETFs
Economy
Frequently Asked Questions
Is State Street SPDR S&P Pharmaceuticals ETF publicly traded?
Yes, State Street SPDR S&P Pharmaceuticals ETF is publicly traded.
What exchange does State Street SPDR S&P Pharmaceuticals ETF trade on?
State Street SPDR S&P Pharmaceuticals ETF trades on the New York Stock Exchange
What is the ticker symbol for State Street SPDR S&P Pharmaceuticals ETF?
The ticker symbol for State Street SPDR S&P Pharmaceuticals ETF is XPH on the New York Stock Exchange
What is the current price of State Street SPDR S&P Pharmaceuticals ETF?
The current price of State Street SPDR S&P Pharmaceuticals ETF is 67.51
When was State Street SPDR S&P Pharmaceuticals ETF last traded?
The last trade of State Street SPDR S&P Pharmaceuticals ETF was at 09/11/26 08:00 PM ET
What is the market capitalization of State Street SPDR S&P Pharmaceuticals ETF?
The market capitalization of State Street SPDR S&P Pharmaceuticals ETF is 2.43M
How many shares of State Street SPDR S&P Pharmaceuticals ETF are outstanding?
State Street SPDR S&P Pharmaceuticals ETF has 2M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
